Smart micelle@polydopamine core-shell nanoparticles for highly effective chemo-photothermal combination therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapy

Background:

• Developing effective combination therapies for cancer is crucial.
• Nanoparticle drug delivery systems offer potential for targeted treatment.
• Integrating multiple therapeutic modalities can enhance efficacy.

Purpose of the Study:

• To design and synthesize a novel core-shell polymer nanoparticle for chemo-photothermal therapy.
• To create a stimuli-responsive drug carrier system for enhanced cancer treatment.
• To investigate the efficacy of combined doxorubicin, bortezomib, and photothermal therapy.

Main Methods:

• Synthesis of a core-shell nanoparticle with a doxorubicin-loaded micelle core and a polydopamine shell.
• Conjugation of bortezomib to the polydopamine shell, creating a pH-sensitive linkage.
• Evaluation of photothermal efficiency, drug release kinetics (pH and NIR-dependent), and in vitro/in vivo cytotoxicity.

Main Results:

• The core-shell nanoparticles (Dox-M@PDA-Btz) demonstrated efficient photothermal conversion for thermal ablation.
• Drug release of doxorubicin and bortezomib was found to be pH- and NIR-dependent.
• Combined therapy using nanoparticles with laser irradiation significantly enhanced cytotoxicity in vitro and in vivo.

Conclusions:

• The developed micelle@polydopamine core-shell nanoparticles are effective for stimuli-responsive drug delivery.
• This nanoplatform enables synergistic chemo-photothermal therapy for breast cancer.
• The system shows promise for advanced, targeted cancer treatment strategies.